Published in J Am Acad Dermatol on June 01, 1983
Erythroderma: review of a potentially life-threatening dermatosis. Indian J Dermatol (2009) 1.27
Erythroderma: a clinical study of 97 cases. BMC Dermatol (2005) 0.98
Erythroderma. A clinical and etiological study of 103 patients. J Dermatol Case Rep (2016) 0.82
Dermacase. Erythroderma secondary to cutanous T-cell lymphoma. Can Fam Physician (2005) 0.80
Three-dimensional miniature endoscopy. Nature (2006) 1.82
Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol (2001) 1.82
Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother (1998) 1.79
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Natl Cancer Inst (1999) 1.71
In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br J Cancer (2009) 1.51
A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer (1994) 1.43
Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem Photobiol (1994) 1.42
Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. Proc Natl Acad Sci U S A (1986) 1.36
Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology (1994) 1.27
Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology (1996) 1.25
Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol (1995) 1.24
Serum insulin and growth hormone response to arginine infusion in healthy and psoriatic persons. Dermatologica (1973) 1.23
Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis. Photochem Photobiol (1998) 1.21
Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res (2000) 1.20
Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res (2001) 1.18
Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res (1996) 1.17
Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer (2006) 1.16
Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer. Cancer Res (2001) 1.15
Photodynamic treatment of rheumatoid and inflammatory arthritis. Photochem Photobiol (1996) 1.13
Comparison of narrowband ultraviolet B exposure and oral vitamin D substitution on serum 25-hydroxyvitamin D concentration. Br J Dermatol (2012) 1.12
Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res (1991) 1.12
Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br J Cancer (1998) 1.12
Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res (1998) 1.11
Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res (1997) 1.10
Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. Br J Cancer (2000) 1.08
Photoluminescence spectroscopy of carbon nanotube bundles: evidence for exciton energy transfer. Phys Rev Lett (2007) 1.07
BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells. Br J Cancer (1999) 1.07
Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library. J Immunol Methods (2001) 1.06
Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Cancer Res (1996) 1.06
The effect of charge on cellular uptake and phototoxicity of polylysine chlorin(e6) conjugates. Photochem Photobiol (1997) 1.06
Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995. Int J Cancer (2000) 1.06
Human sweat kallikrein. Biochemical demonstration and chromatographic separation from several other esteropeptidases in the sweat. Acta Derm Venereol (1970) 1.06
Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol (2010) 1.06
Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology (1994) 1.06
Characterization of a xenograft model of human ovarian carcinoma which produces intraperitoneal carcinomatosis and metastases in mice. Int J Cancer (1996) 1.05
Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Cancer Res (1993) 1.04
Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas. Photochem Photobiol (1996) 1.03
Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urol (1995) 1.03
In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med (1995) 1.01
The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). J Photochem Photobiol B (1995) 1.00
Integrin-mediated adhesion and signalling in ovarian cancer cells. Cell Signal (1998) 1.00
Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br J Cancer (1994) 1.00
Peptidases in the skin. II. Demonstration and partial separation of several specific dipeptide naphthylamidases in the rat and human skin. Arch Klin Exp Dermatol (1969) 1.00
Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells. Br J Cancer (2002) 0.99
Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season. Clin Exp Immunol (2007) 0.99
Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer. Br J Cancer (1997) 0.99
Proteolytic enzymes in the skin. 3. Studies on the extractability, stability and modifier characteristics of the caseinolytic enzymes in the rat skin. Acta Derm Venereol (1969) 0.98
Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors. Phys Med Biol (2012) 0.98
Phototoxicity of lumidoxycycline. J Invest Dermatol (1993) 0.98
In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res (1999) 0.97
Mechanisms of resistance to photodynamic therapy. Curr Med Chem (2011) 0.96
Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy. Br J Cancer (2003) 0.96
Peptidases in the skin. I. Biochemical demonstration of an aminopeptidase in rat skin specific for N-Terminal basic amino acids (Aminopeptidase B). Arch Klin Exp Dermatol (1968) 0.95
The standard erythema dose: a new photobiological concept. Photodermatol Photoimmunol Photomed (1998) 0.95
Rhodamine dyes as potential agents for photochemotherapy of cancer in human bladder carcinoma cells. Cancer Res (1989) 0.94
A multicenter study of patch test reactions with dental screening series. Am J Contact Dermat (2001) 0.94
Effects of in vitro UVA irradiation and PUVA treatment on membrane fatty acids and activities of antioxidant enzymes in human keratinocytes. J Invest Dermatol (1991) 0.94
Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br J Cancer (1997) 0.94
Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model. Br J Cancer (1996) 0.94
Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. Lupus (2008) 0.93
Reverse phase high performance liquid chromatography of Escherichia coli ribosomal proteins: standardization of 70 S, 50 S, and 30 S protein chromatograms. J Biol Chem (1983) 0.93
Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates. Gynecol Oncol (2000) 0.92
Phototoxicity of the tetracyclines: photosensitized emission of singlet delta dioxygen. Proc Natl Acad Sci U S A (1986) 0.91
Absorbed photodynamic dose from pulsed versus continuous wave light examined with tissue-simulating dosimeters. Appl Opt (1997) 0.90
Tm-doped fiber laser mode-locked by graphene-polymer composite. Opt Express (2012) 0.90
Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br J Cancer (2000) 0.90
In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour. Br J Cancer (1999) 0.90
Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents. Cancer Res (1992) 0.89
Cell-mediated immunity in Darier's disease: effect of systemic retinoid therapy. Br J Dermatol (1982) 0.89
p53 expression and clinical outcome in prostate cancer. Br J Urol (1993) 0.88
Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres. Proc Natl Acad Sci U S A (1991) 0.88
Histometric analysis of human skin in organ culture. J Invest Dermatol (1979) 0.88
Mechanism of tetracycline phototoxicity. J Invest Dermatol (1984) 0.88
Epidermal Langerhans cell number and morphology during oral retinoid treatment. Arch Dermatol Res (1982) 0.88
Structural considerations in the metabolism of nitriles to cyanide in vivo. Drug Metab Dispos (1983) 0.88
Proteolytic enzymes in the skin. V. Extraction and column chromatographic separation of the human skin proteinases. Acta Derm Venereol (1971) 0.88
Immunoglobulin E in the human atopic skin. Arch Dermatol Forsch (1973) 0.88
Polymorphous light eruption. A seven-year follow-up evaluation of 114 patients. Arch Dermatol (1984) 0.87
Elastase and trypsin inhibitors of human skin and serum. Partial purification and characterization. Acta Derm Venereol (1971) 0.87
A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study. Acta Derm Venereol (1989) 0.87
Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. J Photochem Photobiol B (1992) 0.87
Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. Circulation (1992) 0.87
The natural history of polymorphous light eruptions. Arch Dermatol (1979) 0.87
Effect of a single UVB or PUVA exposure on immediate and delayed skin hypersensitivity reactions in humans. Correlation to erythemal response and Langerhans cell depletion. Arch Dermatol Res (1983) 0.86
Hormonal modulation of the accumulation of 5-aminolevulinic acid-induced protoporphyrin and phototoxicity in prostate cancer cells. Int J Cancer (1997) 0.86
Tunable Q-switched fiber laser based on saturable edge-state absorption in few-layer molybdenum disulfide (MoS₂). Opt Express (2014) 0.86
Proteolytic enzymes in the skin. II. A comparative study of skin homogenates of five mammalian species. Acta Derm Venereol (1969) 0.86
Supervised four-week heliotherapy alleviates the long-term course of psoriasis. Acta Derm Venereol (1993) 0.86
Vitamin D and prostate cancer. J Steroid Biochem Mol Biol (2001) 0.86
Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins. Br J Cancer (1998) 0.86
Accumulation of matrilysin (MMP-7) and macrophage metalloelastase (MMP-12) in actinic damage. J Invest Dermatol (1999) 0.86
A theoretical study of light fractionation and dose-rate effects in photodynamic therapy. Radiat Res (1997) 0.86
Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light. Br J Cancer (1999) 0.85
Effect of heliotherapy on skin and joint symptoms in psoriasis: a 6-month follow-up study. Br J Dermatol (1993) 0.85
Mechanistic investigation of doxycycline photosensitization by picosecond-pulsed and continuous wave laser irradiation of cells in culture. J Biol Chem (1990) 0.85
Accounting for pharmacokinetic differences in dual-tracer receptor density imaging. Phys Med Biol (2014) 0.85
Reversed-phase high-performance liquid chromatographic separations of tetracycline derivatives using volatile mobile phases. J Chromatogr (1985) 0.85
Sensitivity to Patent Blue dye during skin-prick testing and lymphography. A retrospective and prospective study. Radiology (1981) 0.85
UVB irradiation induces lipid peroxidation and reduces antioxidant enzyme activities in human keratinocytes in vitro. Acta Derm Venereol (1991) 0.84